Literature DB >> 11336261

Insecticidal flavaglines and other compounds from Fijian Aglaia species.

H Grege1, T Pache, B Brem, M Bacher, O Hofer.   

Abstract

Bioassays with lipophilic crude extracts of four Fijian Aglaia species against Spodoptera littoralis displayed strong insecticidal activity for A. basiphylla and A. gracilis, whereas A. archboldiana and A. vitiensis did not have any significant effects. The insect toxicity of A. basiphylla was caused by the well known benzofuran flavaglines rocaglamide, desmethylrocaglamide and aglafoline. In contrast, A. gracilis contained four related pyrimidinone derivatives in the root and stem bark, including two new congeners named marikarin and 3'-hydroxymarikarin. Moreover, two new putrescine bisamides, secoodorine and secopiriferine, a new benzopyran flavagline. desacetylaglain A. and a new norsesquiterpene were isolated from the leaves together with three known bisamides and 3-hydroxy-5,7,4'-trimethoxyflavone. The structures of the new compounds were elucidated by spectroscopic methods. Comparative feeding assays within the active pyrimidinone flavaglines showed that the free hydroxy group in aromatic ring A of marikarin diminishes insecticidal activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11336261     DOI: 10.1016/s0031-9422(00)00471-4

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  11 in total

Review 1.  Chemistry and biology of rocaglamides (= flavaglines) and related derivatives from aglaia species (meliaceae).

Authors:  Sherif S Ebada; Neil Lajkiewicz; John A Porco; Min Li-Weber; Peter Proksch
Journal:  Prog Chem Org Nat Prod       Date:  2011

2.  Cytotoxic flavaglines and bisamides from Aglaia edulis.

Authors:  Soyoung Kim; Young-Won Chin; Bao-Ning Su; Soedarsono Riswan; Leonardus B S Kardono; Johar J Afriastini; Heebyung Chai; Norman R Farnsworth; Geoffrey A Cordell; Steven M Swanson; A Douglas Kinghorn
Journal:  J Nat Prod       Date:  2006-12       Impact factor: 4.050

3.  Chinese herb derived-Rocaglamide A is a potent inhibitor of pancreatic cancer cells.

Authors:  Baochun Wang; Yixiong Li; Fengbo Tan; Zhanxiang Xiao
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

4.  Development of a pharmacodynamic screening model with Crithidia fasciculata.

Authors:  Oumaporn Tasanor; Doris Engelmeier; Brigitte Brem; Ursula Wiedermann-Schmidt; Harald Greger; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2006       Impact factor: 1.704

5.  6α-Acetoxy-gedunin.

Authors:  Margit Hofer; Harald Greger; Kurt Mereiter
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-07-22

6.  Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model.

Authors:  Marie-Eve Bordeleau; Francis Robert; Baudouin Gerard; Lisa Lindqvist; Samuel M H Chen; Hans-Guido Wendel; Brigitte Brem; Harald Greger; Scott W Lowe; John A Porco; Jerry Pelletier
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

7.  Absolute configuration of isoeichlerialactone.

Authors:  Hoong-Kun Fun; Nantiya Joycharat; Supayang Piyawan Voravuthikunchai; Suchada Chantrapromma
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-03-20

8.  Biomimetic kinetic resolution: highly enantio- and diastereoselective transfer hydrogenation of aglain ketones to access flavagline natural products.

Authors:  Steven D Stone; Neil J Lajkiewicz; Luke Whitesell; Ahmed Hilmy; John A Porco
Journal:  J Am Chem Soc       Date:  2014-12-29       Impact factor: 15.419

9.  Development of a pharmacodynamic screening model with Entamoeba histolytica.

Authors:  Oumaporn Tasanor; Brigitte Brem; David Leitsch; Marina Binder; Michael Duchêne; Harald Greger; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 2.275

10.  A phenolic ester from Aglaia loheri leaves reveals cytotoxicity towards sensitive and multidrug-resistant cancer cells.

Authors:  Else Dapat; Sonia Jacinto; Thomas Efferth
Journal:  BMC Complement Altern Med       Date:  2013-10-27       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.